7543 related articles for article (PubMed ID: 1797199)
1. Antitumor effects of alkylphosphocholines in different murine tumor models: use of liposomal preparations.
Zeisig R; Fichtner I; Arndt D; Jungmann S
Anticancer Drugs; 1991 Aug; 2(4):411-7. PubMed ID: 1797199
[TBL] [Abstract][Full Text] [Related]
2. Antineoplastic activity in vitro of free and liposomal alkylphosphocholines.
Zeisig R; Jungmann S; Arndt D; Schütt A; Nissen E
Anticancer Drugs; 1993 Feb; 4(1):57-64. PubMed ID: 8457716
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activity and cross-resistance of carmethizole hydrochloride in preclinical models in mice.
Waud WR; Plowman J; Harrison SD; Dykes DJ; Anderson WK; Griswold DP
Cancer Chemother Pharmacol; 1992; 30(4):261-6. PubMed ID: 1322803
[TBL] [Abstract][Full Text] [Related]
4. Antineoplastic activity of alkylphosphocholines (APC) in human breast carcinomas in vivo and in vitro; use of liposomes.
Fichtner I; Zeisig R; Naundorf H; Jungmann S; Arndt D; Asongwe G; Double JA; Bibby MC
Breast Cancer Res Treat; 1994; 32(3):269-79. PubMed ID: 7865855
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of incorporation characteristics of mitoxantrone into unilamellar liposomes and analysis of their pharmacokinetic properties, acute toxicity, and antitumor efficacy.
Schwendener RA; Fiebig HH; Berger MR; Berger DP
Cancer Chemother Pharmacol; 1991; 27(6):429-39. PubMed ID: 2013113
[TBL] [Abstract][Full Text] [Related]
6. Growth inhibition of human mammary carcinoma by liposomal hexadecylphosphocholine: Participation of activated macrophages in the antitumor mechanism.
Eue I
Int J Cancer; 2001 May; 92(3):426-33. PubMed ID: 11291082
[TBL] [Abstract][Full Text] [Related]
7. In vivo antitumor activity of S 16020-2, a new olivacine derivative.
Guilbaud N; Kraus-Berthier L; Saint-Dizier D; Rouillon MH; Jan M; Burbridge M; Visalli M; Bisagni E; Pierré A; Atassi G
Cancer Chemother Pharmacol; 1996; 38(6):513-21. PubMed ID: 8823492
[TBL] [Abstract][Full Text] [Related]
8. Antitumor and toxicity evaluation of free doxorubicin and doxorubicin entrapped in cardiolipin liposomes.
Rahman A; Fumagalli A; Barbieri B; Schein PS; Casazza AM
Cancer Chemother Pharmacol; 1986; 16(1):22-7. PubMed ID: 3940217
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of sterically stabilized hexadecylphosphocholine liposomes versus conventional liposomes and free hexadecylphosphocholine in tumor-free and human breast carcinoma bearing mice.
Arndt D; Zeisig R; Fichtner I; Teppke AD; Fahr A
Breast Cancer Res Treat; 1999 Nov; 58(1):71-80. PubMed ID: 10634520
[TBL] [Abstract][Full Text] [Related]
10. Systemic administration of alkylphosphocholines. Erucylphosphocholine and liposomal hexadecylphosphocholine.
Kaufmann-Kolle P; Berger MR; Unger C; Eibl H
Adv Exp Med Biol; 1996; 416():165-8. PubMed ID: 9131143
[No Abstract] [Full Text] [Related]
11. Cytotoxic effects of alkylphosphocholines or alkylphosphocholine-liposomes and macrophages on tumor cells.
Zeisig R; Jungmann S; Fichtner I; Daemen T; Arndt D
Anticancer Res; 1994; 14(5A):1785-9. PubMed ID: 7847811
[TBL] [Abstract][Full Text] [Related]
12. Hexadecylphosphocholine differs from conventional cytostatic agents.
Berger MR; Betsch B; Gebelein M; Amtmann E; Heyl P; Scherf HR
J Cancer Res Clin Oncol; 1993; 119(9):541-8. PubMed ID: 8392075
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of free and liposome-entrapped annamycin, a lipophilic anthracycline antibiotic with non-cross-resistance properties.
Zou Y; Ling YH; Van NT; Priebe W; Perez-Soler R
Cancer Res; 1994 Mar; 54(6):1479-84. PubMed ID: 8137251
[TBL] [Abstract][Full Text] [Related]
14. Preclinical in vivo antitumor activity of vinflunine, a novel fluorinated Vinca alkaloid.
Kruczynski A; Colpaert F; Tarayre JP; Mouillard P; Fahy J; Hill BT
Cancer Chemother Pharmacol; 1998; 41(6):437-47. PubMed ID: 9554586
[TBL] [Abstract][Full Text] [Related]
15. Schedule dependence, activity against natural metastases, and cross-resistance of pyrazine diazohydroxide (sodium salt, NSC 361456) in preclinical models in vivo.
Harrison SD; Plowman J; Dykes DJ; Waud WR; Griswold DP
Cancer Chemother Pharmacol; 1990; 25(6):425-9. PubMed ID: 2311170
[TBL] [Abstract][Full Text] [Related]
16. Are syngeneic mouse tumor models still valuable experimental models in the field of anti-cancer drug discovery?
Darro F; Decaestecker C; Gaussin JF; Mortier S; Van Ginckel R; Kiss R
Int J Oncol; 2005 Sep; 27(3):607-16. PubMed ID: 16077908
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of a novel antitumor antibiotic, quinocarmycin citrate (KW2152).
Fujimoto K; Oka T; Morimoto M
Cancer Res; 1987 Mar; 47(6):1516-22. PubMed ID: 2434218
[TBL] [Abstract][Full Text] [Related]
18. Alkylphosphocholines: influence of structural variation on biodistribution at antineoplastically active concentrations.
Kötting J; Berger MR; Unger C; Eibl H
Cancer Chemother Pharmacol; 1992; 30(2):105-12. PubMed ID: 1600590
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity and mechanism of action of the novel marine natural products mycalamide-A and -B and onnamide.
Burres NS; Clement JJ
Cancer Res; 1989 Jun; 49(11):2935-40. PubMed ID: 2720652
[TBL] [Abstract][Full Text] [Related]
20. Biological evaluation of mitoxantrone dihydrochloride synthesized by a new method. I. Acute toxicity and antitumor activity in mouse transplantable tumor systems.
Matuszyk J; Kuśnierczyk H; Radzikowski C
Arch Immunol Ther Exp (Warsz); 1989; 37(1-2):77-88. PubMed ID: 2619512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]